Кожные формы мастоцитоза в детской практике. Клиническое наблюдение пятнисто-папулезной формы мастоцитоза у грудного ребенка

Для цитирования:

Аннотация

Аннотация
Мастоцитоз (МЦ) – представляет собой группу гетерогенных неопластических состояний, характеризующихся повышенной пролиферацией и накоплением тучных клеток в различных органах и тканях. В данной статье представлены новейшая классификация МЦ и принципы диагностики. Отдельно рассмотрена каждая форма кожного МЦ с рекомендациями по ведению пациентов с данным состоянием. В статье приведен клинический пример типичного проявления МЦ у полуторагодовалого ребенка.
Ключевые слова: мастоцитоз, классификация, диагностика, клинический пример.

Список литературы

1. Arock M, Valent P. Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives. Expert Rev Hematol 2010; 3: 497–516.

2. Nettelship E, Tay W. Rare forms of urticarial. BMJ; 1869; 2: 323–30.

3. Sangster A. An anomalous mottled rash, accompanied by pruritus, factitious urticaria and pigmentation, ‘urticaria pigmentosa’ (?). Trans Clin Soc London 1878; 11: 161–3.

4. Ellis JM. Urticaria pigmentosa. A report of a case with autopsy. AMA Arch Pathol 1949; 48: 426–9.

5. Tamay Z, Ozceker D. Current approach to cutaneous mastocytosis in childhood. Turk Pediatri Ars 2016; 51 (3): 123–7.

6. Le M, Miedzybrodzki B, Olynych T et al. Natural history and treatment of cutaneous and systemic mastocytosis. Postgrad Med 2017; 129 (8): 896–901.

7. Brockow K. Epidemiology, prognosis, and risk factors in mastocytosis. Immunol Allergy Clin North Am 2014; 34 (2): 283–95.

8. Потапенко В.Г., Скорюкова К.А. Мастоцитоз у детей и взрослых. Результаты анализа Российской группы пациентов. Клиническая патофизиология. 2017; 23 (3); 54–60.

[Potapenko V.G., Skoriukova K.A. Mastotsitoz u detei i vzroslykh. Rezul'taty analiza Rossiiskoi gruppy patsientov. Klinicheskaia patofiziologiia. 2017; 23 (3); 54–60 (in Russian).]

9. Wilson T, Maric I, Simakova O et al. Clonal analysis of NRAS activating mutations in KIT-D816V systemic mastocytosis. Haematologica 2011; 96 (3): 459–63.

10. Carter MC, Metcalfe DD. Paediatric mastocytosis. Arch Dis Child 2002; 86 (5): 315–19.

11. Цибулькина В.Н., Цибулькин Н.А. Патофизиология тучных клеток при мастоцитозе: значение в клинике и диагностике. Практическая медицина. 2016; 9 (101): 7–11.

[Tsibul'kina V.N., Tsibul'kin N.A. Patofiziologiia tuchnykh kletok pri mastotsitoze: znachenie v klinike i diagnostike. Prakticheskaia meditsina. 2016; 9 (101): 7–11 (in Russian).]

12. Hartmann K, Escribano L, Grattan C et al. Сutaneous manifestations in mastocytosis: consensus report of the European Competence Network on Mastocytosis, the American Academy of Allergy, Asthma & Immunology, and the European Academy of Allergology and Clinical Immunology. J Allergy Clin Immunol 2016; 137 (1): 35–45.

13. Méni C, Bruneau J, Georgin-Lavialle S et al. Paediatric mastocytosis: a systematic review of 1747 cases. Br J Dermatol 2015; 172 (3): 642–51.

14. Arber DA, Orazi A, Hasserjian R et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 2016; 127 (20): 2391–405.

15. Marrouche N, Grattan C. TMEP or not TMEP: that is the question.

J Am Acad Dermatol 2014; 70 (3): 581–2.

16. Pardanani A., Teff eri A. Systemic mastocytosis in adults: a review on prognosis and treatment based on 342 Mayo Clinic patients and current literature. Curr Opin Hematol 2010; 17 (2): 125–32.

17. Valent P, Escribano L, Broesby-Olsen S et al. Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis. Allergy 2014; 69: 1267–74.

18. Uzzaman A, Maric I, Noel P et al. Pediatric-onset mastocytosis: a long term clinical follow-up and correlation with bone marrow histopathology. Pediatr Blood Cancer 2009; 53: 629–34.

19. Ben-Amitai D, Metzker A, Cohen HA. Pediatric cutaneous mastocytosis: a review of 180 patients. Isr Med Assoc J 2005; 7: 320–2.

20. Wiechers T, Rabenhorst A, Schick T et al. Large maculopapular cutaneous lesions are associated with favorable outcome in childhood-onset mastocytosis. J Allergy Clin Immunol 2015; 136 (6): 1581–90.

21. Castells M. Diagnosis and treatment of cutaneous mastocytosis in children: practical recommendations. Am J Clin Dermatol 2011; 12 (4): 259–70.

22. Torrelo A, Alvarez-Twose I, Escribano L. Childhood mastocytosis. Curr Opin Pediatr 2012; 24 (4): 480–6.

23. Bergström A, Rollman O, Emtestam L et al. Cutaneous mastocytosis – update and clinical guidelines. Lakartidningen 2018; Oct 22; 115.

24. Brockow K, Scott LM, Worobec AS et al. Regression of urticaria pigmentosa in adult patients with systemic mastocytosis: correlation with clinical patterns of disease. Arch Dermatol 2002; 138 (6):

785–90.

25. Broesby-Olsen S, Dybedal I, Gülen T et al. Multidisciplinary management of mastocytosis – Nordic expert group consensus. Acta Derm Venereol 2016; 96 (5): 602–12.

26. Lange M, Nedoszytko B, Gorska A et al. Mastocytosis in children and adults: clinical disease heterogeneity. Arch Med Sci 2012; 8: 533–41.

27. Болотная Л.А. Тучные клетки и мастоцитоз. Дерматологiя та венерологiя. 2016; 3 (73): 5–14.

[Bolotnaia L.A. Tuchnye kletki i mastotsitoz. Dermatologiia ta venerologiia. 2016; 3 (73): 5–14 (in Russian).]

28. Matito A, Azaña JM, Torrelo A, Alvarez-Twose I. Cutaneous Mastocytosis in Adults and Children: New Classification and Prognostic Factors. Immunol Allergy Clin North Am 2018; 38 (3): 351–63.

29. Alvarez-Twose I, Jara-Acevedo M, Morgado JM et al. Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis. J Allergy Clin Immunol 2016; 137 (1): 168–78.

30. Carter MC, Clayton ST, Komarow HD, et al. Assessment of clinical findings, tryptase levels, and bone marrow histopathology in the management of pediatric mastocytosis. J Allergy Clin Immunol 2015; 136 (6): 1673–9.

31. Middelkamp Hup MA, Heide R, Tank B et al. Comparison of mastocytosis with onset in children and adults. J Eur Acad Dermatol Venereol 2002; 16 (2): 115–20.

32. Barton J, Lavker RM, Schechter NM et al. Treatment of urticaria pigmentosa with corticosteroids. Arch Dermatol 1985; 121 (12): 1516–23.

33. Потапенко В.Г., Скорюкова К.А., Лисукова Е.В. и др. Мастоцитоз у детей: Характеристика группы 111 пациентов. Педиатрия. Журнал им. Г.Н. Сперанского. 2018; 97 (4): 135–40.

[Potapenko V.G., Skoriukova K.A., Lisukova E.V. et al. Mastotsitoz u detei: Kharakteristika gruppy 111 patsientov. Pediatriia. Zhurnal im. G.N. Speranskogo. 2018; 97 (4): 135–40 (in Russian).]

34. Berezowska S, Flaig MJ, Ruеff F et al. Adult-onset mastocytosis in the skin is highly suggestive of systemic mastocytosis. Mod Pathol 2014; 27 (1): 19–29.

35. Barnes M, Van L, DeLong L et al. Severity of cutaneous findings predict the presence of systemic symptoms in pediatric maculopapular cutaneous mastocytosis. Pediatr Dermatol 2014; 31 (3): 271–5.

36. Verma KK, Bhat R, Singh MK. Bullous mastocytosis treated with oral betamethasone therapy. Indian J Pediatr 2004; 71 (3): 261–3.

37. Patrizi A, Tabanelli M, Neri I et al. Topical corticosteroids versus “wait and see” in the management of solitary mastocytoma in pediatric patients: a long-term follow-up. Dermatol Ther 2015; 28 (2): 57–61.

38. Pyatilova P, Teplyuk N, Olisova O et al. Efficacy of PUVA in Russian patients with mastocytosis: a case series and review of literature. Int J Dermatol 2018; 57 (9): e59-e64. DOI: 10.1111/ijd.14103

Для цитирования:Тамразова О.Б., Глухова Е.А. Кожные формы мастоцитоза в детской практике. Клиническое наблюдение пятнисто-папулезной формы мастоцитоза у грудного ребенка. Клинический разбор в общей медицине. 2020; 1: 60–66. DOI: 10.47407/ kr2020.1.1.00009

Журнал предоставляет свободный доступ с возможностью использовать статьи в некоммерческих целях при условии указания авторства в рамках лицензии CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/deed.ru)

Клинический разбор в общей медицине